RiverFront Investment Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.75M | Sell |
9,424
-490
| -5% | -$91K | 0.03% | 114 |
|
|
2025
Q1 | $2.08M | Buy |
9,914
+6,433
| +185% | +$1.35M | 0.05% | 101 |
|
|
2024
Q4 | $619K | Buy |
3,481
+337
| +11% | +$59.9K | 0.01% | 148 |
|
|
2024
Q3 | $621K | Buy |
3,144
+1,098
| +54% | +$217K | 0.01% | 135 |
|
|
2024
Q2 | $351K | Sell |
2,046
-26
| -1% | -$4.46K | 0.01% | 136 |
|
|
2024
Q1 | $377K | Sell |
2,072
-60,186
| -97% | -$11M | 0.01% | 102 |
|
|
2023
Q4 | $9.65M | Buy |
62,258
+2,464
| +4% | +$382K | 0.3% | 52 |
|
|
2023
Q3 | $8.91M | Buy |
59,794
+5,478
| +10% | +$817K | 0.32% | 50 |
|
|
2023
Q2 | $7.32M | Buy |
54,316
+2,163
| +4% | +$291K | 0.24% | 54 |
|
|
2023
Q1 | $8.31M | Buy |
52,153
+3,133
| +6% | +$499K | 0.29% | 50 |
|
|
2022
Q4 | $1.64M | Sell |
49,020
-6,651
| -12% | -$223K | 0.37% | 53 |
|
|
2022
Q3 | $7.94M | Sell |
55,671
-3,093
| -5% | -$441K | 0.3% | 49 |
|
|
2022
Q2 | $9M | Buy |
+58,764
| New | +$9M | 0.34% | 49 |
|